915771-22-1

Basic information

• Product Name: Benzoic acid, 3-(phenylmethoxy)-5-[[(3S)-tetrahydro-3-furanyl]oxy]-, methyl ester
• CAS NO: 915771-22-1
• Molecular Formula: C19H20O5
• Molecular Weight: 328.365
• Mol File: 915771-22-1.mol

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-(phenylmethoxy)-5-[[(3S)-tetrahydro-3-furanyl]oxy]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-(phenylmethoxy)-5-[[(3S)-tetrahydro-3-furanyl]oxy]-, methyl ester(915771-22-1)
• EPA Substance Registry System: Benzoic acid, 3-(phenylmethoxy)-5-[[(3S)-tetrahydro-3-furanyl]oxy]-, methyl ester(915771-22-1)

Safety Data

• Hazardous Substances Data: 915771-22-1(Hazardous Substances Data)

Upstream product

• 54915-31-0 methyl 3-(benzyloxy)-5-hydroxybenzoate 
• 219823-47-9 (R)-tetrahydrofuran-3-yl 4-methylbenzenesulfonate 
• 100-39-0 benzyl bromide 
• 2150-44-9 1-carbomethoxy-3,5-dihydroxybenzene 

Downstream Products

• 915771-44-7 methyl 3-hydroxy-5-[(3S)-tetrahydrofuran-3-yloxy]benzoate 
• 915771-19-6 3-hydroxy-N-(5-methylpyrazin-2-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide 
• 915771-20-9 N-(5-methylpyrazin-2-yl)-3-[(phenylmethyl)oxy]-5-[(3S)-tetrahydrofuran-3-yloxy]benzamide 
• 915771-42-5 methyl 3-[(3-methyl-4-oxo-3,4-dihydro-2H-1,3-benzoxazin-7-yl)oxy]-5-[(3S)-tetrahydrofuran-3-yloxy]benzoate 
• 915771-52-7 methyl 3-[(9-chloro-4-methyl-5-oxo-2,3,4,5-tetrahydro-1,4-benzoxazepin-8-yl)oxy]-5-[(3S)-tetrahydrofuran-3-yloxy]benzoate 
• 915948-99-1 3-{[6-(azetidin-1-ylcarbonyl)pyridin-3-yl]oxy}-5-[(3S)-tetrahydrofuran-3-yloxy]benzoic acid 
• 915948-97-9 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-[(3S)-tetrahydrofuran-3-yloxy]benzoic acid 
• 915948-96-8 methyl 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-[(3S)-tetrahydrofuran-3-yloxy]benzoate 
• 915949-10-9 8-{3-[(phenylmethyl)oxy]-5-[(3S)-tetrahydrofuran-3-yloxy]phenyl}-9H-purine 
• 915949-09-6 3-(9H-purin-8-yl)-5-[(3S)-tetrahydrofuran-3-yloxy]phenol 

Relevant articles and documents

HETEROARYLCARBAMOYLBENZENE DERIVATIVES FOR THE TREATMENT OF DIABETES

Compounds of formula (I) wherein R1, R2, R3 and HET-1 are as described in the specification, and their salts, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.

HETEROARYL BENZAMIDE DERIVATIVES FOR USE AS GLK ACTIVATORS IN THE TREATMENT OF DIABETES

Compounds of formula (I), wherein R1, R4, HET-1 and HET-2 are as described in the specification, and their salts and pro-drugs, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.

2-PHENYL SUBSTITUTED IMIDAZOL [4 , 5B] PYRIDINE/ PYRAZINE AND PURINE DERIVATIVES AS GLUCOKINASE MODULATORS

Compounds of Formula (I), wherein R1- R10, A and X1 to X3 are as described in the specification, and their salts and pro-drugs, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of formula (I) are also described.